Kaipu Biology: Proposes to Use No More Than 800 Million Yuan of Idle Self-Owned Funds for Cash Management

NightAirdropper · 2026-03-20T20:47:18+00:00

Cape Bio held a board meeting on March 18, 2026, approving the use of no more than 800 million yuan of idle self-owned funds for cash management, investing in safe, high-liquidity wealth management products with a term not exceeding 12 months, without affecting the company's normal operations.

NightAirdropper

2026-03-20 20:47:18

Abstract generation in progress

Everyday Economic News AI Express, March 18 — Capbio announced that on March 18, 2026, the sixth board of directors will hold its fourth meeting to review and approve the proposal on using idle funds for cash management. The company and its subsidiaries within the consolidated scope agree to use no more than 800 million yuan of idle funds for cash management, investing in high-security, liquid financial products, including but not limited to financial products issued by commercial banks, securities firms, trust companies, and other financial institutions, such as trust products and asset management plans. The investment period shall not exceed 12 months from the date of approval by the board; funds within the limit can be rolled over; this will not affect the company’s normal production, operations, or main business activities.

Daily Economic News

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes